Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
Simple search

Simple search

*
(*) mandatory field




 

Other search option(s)

350 matching term(s)

Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (mutation G20210A of F2 gene)
    • Laboratoire Cerba
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Molecular diagnosis of factor V Leiden (mutations R506Q)
    • Laboratoire Cerba
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Molecular diagnosis of homcystinuria due to C677T variant of MTHFR gene
    • Laboratoire Cerba
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (MTHFR gene)
    • CHU de Marseille - Hôpital de la Timone
    • More information
    • FRANCE
    • BRETAGNE
    • LORIENT
    • Accreditation
    • Molecular diagnosis of resistance to activated protein C (F5 gene)
    • BIOLOR
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (Leiden mutation; G20210A mutation in F2 gene; C677T variant in MTHFR gene)
    • CHRU de Lille - Centre de biologie pathologie génétique
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Accreditation
    • Molecular diagnosis of thrombosis risks (F5, F2 genes)
    • CHU de Marseille - Hôpital de la Timone
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Accreditation
    • Molecular diagnosis of thrombosis risks (F2, F5)
    • CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Medizinische Hochschule Hannover
    • More information
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Accreditation
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Universitätsmedizin Göttingen
    • More information
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Universitätsmedizin Göttingen
    • More information
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Universitätsmedizin Göttingen
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of factor V deficiency and resistance to activated protein C
    • Labor Lademannbogen
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Labor Lademannbogen
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Labor Lademannbogen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (FII, FV, MTHFR genes)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Bayern
    • BAD STEBEN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Institut für angewandte Humangenetik und Onkogenetik
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Pränatalmedizin München
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Medizinisches Versorgungszentrum Humane Genetik
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Medizinisches Versorgungszentrum Humane Genetik
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
    • Medizinisches Versorgungszentrum Humane Genetik
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Medizinisches Versorgungszentrum Humane Genetik
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÖNCHENGLADBACH
    • Accreditation
    • Biochemical diagnosis of congenital plasminogen activator inhibitor type 1 deficiency
    • Medizinische Versorgungszentrum Dr.Stein + Kollegen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÖNCHENGLADBACH
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Medizinische Versorgungszentrum Dr.Stein + Kollegen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÖNCHENGLADBACH
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Medizinische Versorgungszentrum Dr.Stein + Kollegen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÖNCHENGLADBACH
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Medizinische Versorgungszentrum Dr.Stein + Kollegen
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • IVRY SUR SEINE
    • Accreditation
    • Molecular diagnosis of MTHFR thermolabile variant (C677T mutation)
    • Biomnis
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • IVRY SUR SEINE
    • Accreditation
    • FRANCE
    • ILE-DE-FRANCE
    • IVRY SUR SEINE
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (F2 gene)
    • Biomnis
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Paxis und Labor Dr. med Karl Mehnert
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Paxis und Labor Dr. med Karl Mehnert
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Accreditation
    • Molecular diagnosis of predisposition to thrombophilia. F5 gene.
    • Laboratorio de Análisis Dr. Echevarne
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Medizinisch Genetisches Zentrum München
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Medizinisch Genetisches Zentrum München
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Medizinisch Genetisches Zentrum München
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • ZÜRICH
    • Accreditation
    • Molecular diagnosis of factor V deficiency and resistance to activaded protein C (F5 gene)
    • Genetica AG
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of congential plasminogen activator inhibitor type 1 deficiency
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Accreditation
    • Molecular diagnosis of Non rare thrombophilia (R506Q - Factor V Leiden)
    • University Hospitals Leuven - Gasthuisberg
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Accreditation
    • Molecular diagnosis of Non rare thrombophilia (Factor II 20210G>A variant)
    • University Hospitals Leuven - Gasthuisberg
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Accreditation
    • Molecular diagnosis of Non rare thrombophilia (MTHFR C677T variant)
    • University Hospitals Leuven - Gasthuisberg
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN-EDEGEM
    • Accreditation
    • Molecular diagnosis of APC resistance due to Factor V Leiden (F5 gene)
    • University and University Hospital of Antwerp - UZA
    • More information
    • SWITZERLAND
    • Suisse Romande
    • SION
    • Accreditation
    • Molecular diagnosis of thrombophilia (F5 gene: G1691A and H1299R; F2 gene: G20210A; MTHFR gene: C677T and A1298C; F13A1 gene: V34L; PROCR gene: A4600G and G4678C; and 4G/5G polymorphism in the promoter of the PAI1 gene).
    • Institut Central des Hôpitaux Valaisans (ICHV)
    • More information
    • UNITED KINGDOM
    • Lanarkshire
    • GLASGOW
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
    • Southern General Hospital
    • More information
    • UNITED KINGDOM
    • Lanarkshire
    • GLASGOW
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (F5 gene: G1691A mutation)
    • Southern General Hospital
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of thrombophilia (F5: factor V Leiden mutation, factor V Cambridge mutation, and others)
    • Gemeinschaftspraxis Dr. Prager / Dr. Junge / Dr. Hennig / Dr. Linné
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
    • Gemeinschaftspraxis Dr. Prager / Dr. Junge / Dr. Hennig / Dr. Linné
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (MTHFR gene variant C677T, F2 gene, F5 gene)
    • Allgemeines Krankenhaus der Stadt Wien
    • More information
    • UNITED KINGDOM
    • Devon
    • EXETER
    • Accreditation
    • Molecular diagnosis of Congenital Factor V Deficiency (Leiden)
    • Royal Devon and Exeter Hospital - Wonford site
    • More information
    • UNITED KINGDOM
    • Devon
    • EXETER
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
    • Royal Devon and Exeter Hospital - Wonford site
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular diagnosis of Factor V Deficiency - Leiden (F5: specific mutation analysis)
    • Salisbury District Hospital
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular diagnosis of Hyperprothrombinemia (Prothrombin 20210A mutation)
    • Salisbury District Hospital
    • More information
    • UNITED KINGDOM
    • Nottinghamshire
    • NOTTINGHAM
    • Accreditation
    • Molecular diagnosis of thrombophilia risk factors (multiplex analysis of the prothrombin 20210G>A and F5 c.1601G>A variants )
    • Queen's Medical Centre
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Accreditation
    • Molecular diagnosis of thrombophilia by genotyping (Factor V Leiden and Prothrombin G20210A)
    • Central Manchester University Hospitals - Manchester Royal Infirmary
    • More information
    • UNITED KINGDOM
    • Greater London
    • HARROW
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A, F2 gene)
    • North West London Hospitals NHS - Northwick Park & St Marks Hospital
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • GenteQ GmbH
    • More information
    • GERMANY
    • Sachsen
    • WEIßWASSER
    • Accreditation
    • Molecular diagnosis of factor V deficiency and resistance to activated protein C (F5 gene: fragment analysis and sequencing of selective regions)
    • Praxis Dr. Mato Nagel
    • More information
    • BELGIUM
    • HAINAUT
    • GOSSELIES
    • Accreditation
    • Molecular diagnosis of non-rare thrombophilia (Factor 2 20210G>A variant)
    • Institut de Pathologie et de Génétique - Gosselies
    • More information
    • UNITED KINGDOM
    • Grampian
    • ABERDEEN
    • Accreditation
    • Molecular diagnosis of Factor V Deficiency (Leiden)
    • Aberdeen Royal Infirmary, Polwarth Building
    • More information
    • UNITED KINGDOM
    • Grampian
    • ABERDEEN
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
    • Aberdeen Royal Infirmary, Polwarth Building
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Factor V deficiency (Leiden plus complete F5 gene)
    • St Thomas' Hospital
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Methylenetetrahydrofolate Reductase Deficiency (MTHFR), thermolabile variant (C677T)
    • St Thomas' Hospital
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Congenital Factor II deficiency (20210A plus complete Prothrombin gene)
    • St Thomas' Hospital
    • More information
    • SWITZERLAND
    • Suisse Romande
    • LAUSANNE
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (F2 gene, F5 gene)
    • synlab SUISSE
    • More information
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Accreditation
    • Molecular diagnosis of thrombophilia: factor V Leiden (F5 gene: R534Q (p.R506Q) mutation) and factor II (F2 gene G20210A mutation )
    • Addenbrooke's Hospital
    • More information
    • UNITED KINGDOM
    • Avon
    • BRISTOL
    • Accreditation
    • Molecular diagnosis of resistance to activated protein C - Factor V Leiden (F5 gene, G1691A mutation)
    • Southmead Hospital
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • BRNO
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and CFTR genes)
    • Cytogenetic laboratory Brno,s.r.o.
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation, F2 gene: G20210A variant, MTHFR gene: C667T and A1298C variants)
    • Asper Biotech Ltd.
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Accreditation
    • Molecular diagnosis of resistance to activated protein C (F5 gene: R506Q mutation)
    • BioAnalytica-GenoType SA
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
    • BioAnalytica-GenoType SA
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Accreditation
    • Molecular diagnosis of MTHFR deficiency (C677T and A1298C mutations)
    • BioAnalytica-GenoType SA
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Centogene AG
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • VALENCIENNES
    • Accreditation
    • Molecular diagnosis of thrombosis risks (F2 gene: G20210A mutation; F5 gene: Leiden mutation; MTHFR gene)
    • Centre Hospitalier de Valenciennes
    • More information
    • FINLAND
    • Finland
    • HELSINKI
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
    • Yhtyneet Medix Laboratoriot
    • More information
    • FINLAND
    • Finland
    • HELSINKI
    • Accreditation
    • Molecular diagnosis of factor V deficiency (F5 gene: G1691A mutation)
    • Yhtyneet Medix Laboratoriot
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Molecular diagnosis of thrombophilia (F5: factor V Leiden mutation, factor V Cambridge mutation, H1299R)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Zentrum für Humangenetik
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Zentrum für Humangenetik
    • More information
    • UNITED KINGDOM
    • South Glamorgan
    • CARDIFF
    • Accreditation
    • Molecular diagnosis of MTHFR deficiency due to C667T thermolabile variant
    • University Hospital of Wales
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (MTHFR gene)
    • CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • NICE
    • Accreditation
    • Molecualr diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A mutation)
    • CHU de Nice - Hôpital Pasteur
    • More information
    • SWITZERLAND
    • Suisse Italienne
    • LUGANO
    • Accreditation
    • Molecular diagnosis of resistance to activated protein C
    • Procrea Lab SA - Laboratorio di Genetica Molecolare
    • More information
    • SWITZERLAND
    • Suisse Italienne
    • LUGANO
    • Accreditation
    • Molecular diagnosis of Congenital factor II deficiency
    • Procrea Lab SA - Laboratorio di Genetica Molecolare
    • More information
    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia: factor II (gene F2 mutation G20210A)
    • Hôpitaux Universitaires de Genève HUG
    • More information
    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Molecualr diagnosis of non rare thrombophilia (F5 gene: Leiden (R506Q) mutation detection)
    • Hôpitaux Universitaires de Genève HUG
    • More information
    • GERMANY
    • Baden-Württemberg
    • SINGEN /HTWL.
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Institut für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Baden-Württemberg
    • SINGEN /HTWL.
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Institut für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Baden-Württemberg
    • SINGEN /HTWL.
    • Accreditation
    • Molecular diagnosis of MTHFR gene variant C677T
    • Institut für Laboratoriumsmedizin und Humangenetik
    • More information
    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Molecular diagnosis of Factor V Deficiency (Leiden)
    • Hôpitaux Universitaires de Genève HUG
    • More information
    • UNITED KINGDOM
    • Devon
    • PLYMOUTH
    • Accreditation
    • Molecular diagnosis of hyperprothrombinemia (Prothrombin 20210A mutation)
    • Plymouth Derriford Hospital
    • More information
    • UNITED KINGDOM
    • Devon
    • PLYMOUTH
    • Accreditation
    • Molecular diagnosis of Congenital Factor V Deficiency (Leiden, F5 gene G617A mutation)
    • Plymouth Derriford Hospital
    • More information
    • CZECH REPUBLIC
    • Plzen
    • KLATOVY
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (G20210A variant of the F2 gene)
    • BioLab spol. s.r.o.
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Accreditation
    • Molecular diagnosis of factor V Leiden mutation
    • Universitätsklinikum Heidelberg
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Accreditation
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Universitätsklinikum Heidelberg
    • More information
    • CZECH REPUBLIC
    • South Bohemia
    • CESKE BUDEJOVICE
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F5 and F2 genes)
    • Centrum lekarske genetiky s.r.o.
    • More information
    • CZECH REPUBLIC
    • Plzen
    • PLZEN
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • Genetika Plzen
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • HODONIN
    • Accreditation
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • Chemila, spol. s r.o.
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Accreditation
    • Molecular diagnosis of thrombophilia (marker FV, FII, MTHFR, 4G/5G polymorphism in the promoter of the PAI1 gene)
    • Labor Prof. Dr. G. Enders MVZ
    • More information
    • CANADA
    • Ontario
    • MISSISSAUGA
    • Accreditation
    • Molecular diagnosis of non-rare Thrombophilia (by F2, FV Allele-specific PCR)
    • Trillium Health Partners- Credit Valley Site
    • More information
    • FRANCE
    • AUVERGNE
    • CLERMONT-FERRAND
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • Faculté de médecine de Clermont-Ferrand
    • More information
    • FRANCE
    • LORRAINE
    • VANDOEUVRE-LÈS-NANCY
    • Molecular diagnosis of non rare thrombophilia (F5 gene : Leiden mutations ; F2 gene : G20210A mutation)
    • CHU de Nancy - Hôpital de Brabois
    • More information
    • FRANCE
    • AQUITAINE
    • BORDEAUX
    • Molecular diagnosis of non rare thrombophilia (MTHFR gene)
    • CHU de Bordeaux-GH Pellegrin
    • More information
    • FRANCE
    • BRETAGNE
    • BREST
    • Molecular diagnosis of risk factors for thrombosis (F5 and F2 genes)
    • CHRU de Brest - Hôpital Morvan
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • LE CHESNAY
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • CH de Versailles - Hôpital André Mignot
    • More information
    • FRANCE
    • LORRAINE
    • EPINAL
    • Molecular genetics diagnosis ofnon rare thrombophilia (F2, F5 genes)
    • Analysis - Laboratoire Lefaure & Petit
    • More information
    • FRANCE
    • MIDI-PYRENEES
    • TOULOUSE
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • CHU de Toulouse - Hôpital Purpan
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Molecular diagnosis of non rare thrombophilia (Leiden mutation in the F5 gene and G20210A variant in the F2 gene)
    • CHU de Reims - Hôpital Robert Debré
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • POISSY
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • Centre hospitalier intercommunal Poissy-Saint-Germain-en-Laye
    • More information
    • FRANCE
    • RHONE-ALPES
    • GRENOBLE
    • Molecular diagnosis of non rare thrombophilia (mutation search in F5, F2, MTHFR genes)
    • CHU de Grenoble site Nord - Institut de biologie et de pathologie
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • LE MANS
    • Molecular diagnosis of thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A mutation)
    • Centre hospitalier
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • LE KREMLIN-BICÊTRE
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • GHU Paris-Sud - Hôpital de Bicêtre
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • CHU Paris - Hôpital Robert Debré
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of thrombosis risks (F2, F5 and MTHFR genes)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • More information
    • FRANCE
    • POITOU-CHARENTES
    • POITIERS
    • Molecular diagnosis of non rare thrombophilia
    • CHU de Poitiers
    • More information
    • FRANCE
    • PICARDIE
    • AMIENS
    • Molecular diagnosis of non rare thrombophilia (F2, F5 genes and C677T , A1298C mutations in MTHFR gene)
    • CHU d'Amiens - Hôpital Sud
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
    • CHU de Strasbourg - Hôpital de Hautepierre
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of non rare thrombophilia
    • CHU Paris - Hôpital Necker-Enfants Malades
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • CHU Paris Est - Hôpital Saint-Antoine
    • More information
    • ITALY
    • TOSCANA
    • PISA
    • Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
    • Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
    • More information
    • FRANCE
    • BASSE-NORMANDIE
    • CAEN
    • Molecular diagnosis of thrombosis risks (F5 and F2 genes)
    • CHU de Caen - Hôpital de la Côte de Nacre
    • More information
    • ITALY
    • LOMBARDIA
    • CUSANO MILANINO
    • Molecular diagnosis of thrombophilia risks (F5, F2 and MTHFR genes)
    • Istituto Auxologico Italiano
    • More information
    • ITALY
    • VENETO
    • COSTOZZA DI LONGARE
    • Molecular diagnosis of thrombophilia (F5 gene)
    • B.I.R.D. Foundation
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of non rare trombophilia (FII, FV, MTHFR genes)
    • Istituto CSS-Mendel
    • More information
    • FRANCE
    • ALSACE
    • MULHOUSE
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • CH de Mulhouse - Hôpital Emile Muller
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of factor V Leiden mutation
    • Policlinico Umberto I
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of factor V Leiden mutation
    • Praxis für medizinische Genetik
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • AACHEN
    • Molecular diagnosis of factor V Leiden mutation
    • Universitätsklinikum Aachen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • AACHEN
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Universitätsklinikum Aachen
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of non rare thrombophilia (R506Q mutation detection in F5 gene)
    • Hospital Universitario Central de Asturias
    • More information
    • GERMANY
    • Bayern
    • ERLANGEN
    • Molecular diagnosis of factor V Leiden mutation
    • Universitätsklinikum Erlangen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • ESSEN
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
    • Laborärztlich-humangenetische Partnerschaft Eiben - Glaubitz
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • ESSEN
    • Molecular diagnosis of factor V Leiden mutation
    • Laborärztlich-humangenetische Partnerschaft Eiben - Glaubitz
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Molecular diagnosis of factor V Leiden mutation
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • More information
    • FRANCE
    • BRETAGNE
    • QUIMPER
    • Molecular diagnosis of thrombosis risks (F5 gene: Leiden mutation; F2 and MTHFR genes)
    • CHI de Cornouaille
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of thrombophilia (F2, F5 and MTHFR genes)
    • Groupe Hospitalier Paris Saint-Joseph
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • BOBIGNY
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • CHU Paris Seine-Saint-Denis - Hôpital Avicenne
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Molecular diagnosis of factor V Leiden mutation
    • Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Molecular diagnosis of non rare thrombophilia (gene variant C677T)
    • Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
    • More information
    • FRANCE
    • RHONE-ALPES
    • SAINT-PRIEST-EN-JAREZ
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • CHU de Saint-Etienne - Hôpital Nord
    • More information
    • FRANCE
    • CENTRE
    • TOURS
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • CHRU de Tours - Hôpital Trousseau
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • MEAUX
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • CH de l'Est Francilien, site de Meaux
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • PARMA
    • Molecular diagnosis of non rare trombophilia (F2, F5, MTHFR genes)
    • Azienda Ospedaliera Universitaria di Parma
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Analysis of thrombosis predisposition genetic factors (MTHFR C667T and A1298C, PAI-1 -675G>A; F5: 1691 G>A; F2: 20210 G>A)
    • Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
    • More information
    • GERMANY
    • Niedersachsen
    • HILDESHEIM
    • Molecular diagnosis of factor V Leiden mutation
    • Gemeinschaftspraxis Dres. Algermissen / Justus / Wilke / Graf
    • More information
    • ITALY
    • SICILIA
    • CATANIA
    • Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
    • CPSS - Centro Polidiagnostico Servizi Sanitari
    • More information
    • FRANCE
    • AQUITAINE
    • BORDEAUX
    • Molecular diagnosis of non rare thrombophilia (F5, F2 genes)
    • CHU de Bordeaux-GH Pellegrin
    • More information
    • SPAIN
    • Navarra
    • PAMPLONA
    • Molecular diagnosis of Predisposition to thrombophilia. F5 gene
    • Hospital Virgen del Camino
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • Sistemas Genómicos S.L.
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • Hospital Universitario La Fe - Campanar
    • More information
    • AUSTRIA
    • OBERÖSTERREICH
    • LINZ
    • Molecular diagnosis of non rare thrombophilia (F5: Leiden mutation (G1691A); F2: G20210A; MTHFR: C677T and A1298C)
    • Krankenhaus der Barmherzigen Schwestern Linz
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Molecular diagnosis of non-rare thrombophilia (factor V-Leiden mutation)
    • Medizinische Universität Graz
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Molecular diagnosis of hyperprothrombinemia (Prothrombin G20210A mutation)
    • Tartu University Hospital
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Molecular diagnosis of factor V Leiden
    • Tartu University Hospital
    • More information
    • SPAIN
    • Aragón
    • ZARAGOZA
    • Molecular diagnosis of non rare thrombophilia (Leiden mutation in F5 gene, G20210A variant in F2 gene and C677T in MTHFR gene)
    • Hospital Universitario Miguel Servet
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of factor V Leiden mutation
    • Praxis Dres. Gencik
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of MTHFR gene variant C677T
    • Praxis Dres. Gencik
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
    • Praxis Dres. Gencik
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of factor V Leiden mutation
    • Medizinische Universität Wien
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of factor V Leiden mutation
    • Klinikum Stuttgart - Standort Olgahospital
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Klinikum Stuttgart - Standort Olgahospital
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of congenital factor II deficiency (F2 gene: Target mutation analysis - single mutation, G20210A mutation)
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of predisposition to thrombophilia (F5 gene: targeted mutation analysis - single mutation (R506Q))
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • REINACH
    • Molecular diagnosis of factor V deficiency and resistance to activated protein C (Leiden, R506Q mutation)
    • Diagene Laboratories Inc.
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • REINACH
    • Molecular diagnosis of Homocystinuria due to Methylene Tetrahydrofolate Reductase deficiency (MTHFR gene: C677T mutation)
    • Diagene Laboratories Inc.
    • More information
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
    • CHU de Lyon HCL - GH Edouard Herriot
    • More information
    • ITALY
    • LOMBARDIA
    • BUSTO ARSIZIO
    • Molecular diagnosis of thrombophilia risks (F5, F2 and MTHFR genes)
    • Toma Advanced Biomedical Assays S.p.A.
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular diagnosis of non rare thrombophilia (F5 gene: mut. G1691A; F2 gene: mut. G20210A; MTHFR gene: mut. C677T, mut. A1298C)
    • Centro Inmunológico de Alicante (CIALAB)
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Molecular diagnosis of Non rare thrombophilia (Factor V Leiden - R506Q)
    • Universitair Ziekenhuis Brussel - UZBrussel
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Molecular test for predisposition to thrombophilia (F2 gene - 20210G>A)
    • Universitair Ziekenhuis Brussel - UZBrussel
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • MAINZ
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Institut für Klinische Genetik Mainz
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • MAINZ
    • Molecular diagnosis of factor V Leiden mutation
    • Institut für Klinische Genetik Mainz
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • MAINZ
    • Molecular diagnosis of MTHFR gene variant C677T
    • Institut für Klinische Genetik Mainz
    • More information
    • CZECH REPUBLIC
    • Moravia-Silesia
    • OSTRAVA
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • CGB laboratory Ltd.
    • More information
    • CZECH REPUBLIC
    • Capital City Prague
    • PRAHA
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2: G20210A variant; MTHFR gene)
    • Gennet s.r.o.
    • More information
    • NORWAY
    • Vestlandet
    • BERGEN
    • Molecular diagnosis of factor V Leiden (F5 gene)
    • Haukeland University Hospital
    • More information
    • HUNGARY
    • Észak-Magyarország
    • BUDAPEST
    • Molecular diagnosis of resistance to activated protein C by melting point analysis of F5 gene
    • Semmelweis University
    • More information
    • SLOVENIA
    • SLOVENIA
    • MARIBOR
    • Molecular diagnosis of non rare thrombophilia
    • Maribor general hospital
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÜNSTER
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Universitätsklinikum Münster
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÜNSTER
    • Molecular diagnosis of factor V Leiden mutation
    • Universitätsklinikum Münster
    • More information
    • TURKEY
    • TURKEY
    • ANKARA
    • Molecular diagnosis of non rare thrombophilia (Leiden mutation in the F5 gene; G20210A mutation in the F2 gene; MTHFR C677T polymorphism)
    • Intergen Genetics Center
    • More information
    • CROATIA
    • CROATIA
    • ZAGREB
    • Molecular diagnosis of Factor V Deficiency (Leiden)
    • Zagreb Clinical Hospital Center
    • More information
    • SERBIA
    • Serbia
    • BELGRADE
    • Molecular diagnosis of Factor V Deficiency (Leiden)
    • Institute of Molecular Genetics and Genetic Engineering
    • More information
    • LATVIA
    • LATVIA
    • RIGA
    • Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR gene: search for specific mutations)
    • Riga Stradins University
    • More information
    • FRANCE
    • BOURGOGNE
    • DIJON
    • Molecular diagnosis of non rare thrombophilia (F5, F2 MTHFR genes)
    • CHU de Dijon - Plateau technique de Biologie
    • More information
    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • Molecular diagnosis of Factor V Leiden mutation
    • Medizinische Universität Innsbruck
    • More information
    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • Molecular diagnosis of hereditary thrombophilia (F2 gene)
    • Medizinische Universität Innsbruck
    • More information
    • SLOVENIA
    • SLOVENIA
    • LJUBLJANA
    • Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
    • University Medical Center Ljubljana
    • More information
    • POLAND
    • Poznan
    • POZNAN
    • Molecular diagnosis of risk factors for thrombophilia (Leiden mutation in F5 gene; G20210A variant in F2 gene; C677T in MTHFR gene - RFLP analysis)
    • NZOZ Centrum Genetyki Medycznej Genesis
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Diagenom GmbH
    • More information
    • ISRAEL
    • ISRAEL
    • TEL AVIV
    • Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
    • Pronto Diagnostics Ltd.
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of factor V Leiden mutation
    • Pränatalzentrum Hamburg und Humangenetik
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Pränatalzentrum Hamburg und Humangenetik
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of MTHFR gene variant C677T
    • Pränatalzentrum Hamburg und Humangenetik
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of resistance to activated protein C. F5 gene.
    • Genetaq
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of non rare thrombophilia (F5, F2, MTHFR genes)
    • Genetaq
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • AULNAY-SOUS-BOIS
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 gene)
    • Centre Hospitalier Robert Ballanger
    • More information
    • FRANCE
    • ALSACE
    • COLMAR
    • Molecular diagnosis of thrombosis risks (F5 gene : R506Q mutation; F2 gene: G20210A mutation)
    • Hôpital Pasteur - Hôpitaux civils de Colmar
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LENS
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • Centre hospitalier de Lens
    • More information
    • CZECH REPUBLIC
    • Hradec Kralove
    • HRADEC KRALOVE
    • Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
    • Medical Genetics Laboratory
    • More information
    • CZECH REPUBLIC
    • Hradec Kralove
    • HRADEC KRALOVE
    • Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
    • Medical Genetics Laboratory
    • More information
    • CZECH REPUBLIC
    • Hradec Kralove
    • HRADEC KRALOVE
    • Molecular diagnosis of MTHFR thermolabile variant: C677T mutation
    • Medical Genetics Laboratory
    • More information
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Molecular diagnosis of risk factors for thrombophilia (Leiden variant in F5 gene; G20210A variant in F2 gene and C677T in MTHFR gene)
    • Laboratoire Alpigene
    • More information
    • FRANCE
    • LORRAINE
    • SAINT-DIÉ DES VOSGES
    • Molecular diagnosis of risk factors for thrombophilia (Leiden mutation in F5 gene, G20210A variant in F2 gene and C677T in MTHFR gene)
    • Laboratoire Biolam
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • NÎMES
    • Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
    • CHU de Nîmes - Hôpital Caremeau
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • NÎMES
    • Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A polymorphism)
    • CHU de Nîmes - Hôpital Caremeau
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • NÎMES
    • Molecular diagnosis of non rare thrombophilia (F12 gene: C46T polymorphism)
    • CHU de Nîmes - Hôpital Caremeau
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • NÎMES
    • Molecular diagnosis of non rare thrombophilia (PROCR gene: mutation A6936G)
    • CHU de Nîmes - Hôpital Caremeau
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • TROYES
    • Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
    • CHG Les Hauts Clos
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • TROYES
    • Molecular diagnosis of hyperprothrombinemia (F2 gene)
    • CHG Les Hauts Clos
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • TROYES
    • Search of MTHFR gene variants as risk factors for thrombophilia
    • CHG Les Hauts Clos
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-MANDÉ
    • Molecular diagnosis of resistance to activated protein C (F5 gene: Leiden mutation)
    • Hôpital d'Instruction des Armées Bégin
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-MANDÉ
    • Molecular diagnosis of hyperprothrombinemia (F2 gene: G20210A mutation)
    • Hôpital d'Instruction des Armées Bégin
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • GARCHES
    • Molecular diagnosis of thrombophilia (gène MTHFR ; F5 gene: Leiden mutation; F2 gene: G20210A mutation search by PCR)
    • GHU Paris Ile-de-France Ouest - Hôpital Raymond Poincaré
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • MONTFERMEIL
    • Molecular diagnosis of thrombophilia risk factors (F5 gene: Leiden mutation; F2 gene: G20210 mutation ; PCR analysis)
    • GHI Le Raincy-Montfermeil
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-DENIS
    • Molecular diagnosis of thrombophilia risk factors (F5 gene: Leiden mutation; F2 gene: G20210A mutation)
    • Centre Hospitalier de Saint-Denis
    • More information
    • FRANCE
    • FRANCHE-COMTE
    • BESANÇON
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • EFS - Bourgogne/Franche-Comté
    • More information
    • FRANCE
    • FRANCHE-COMTE
    • BESANÇON
    • Molecular diagnosis of non rare thromphilia (C677T variant in MTHFR gene)
    • EFS - Bourgogne/Franche-Comté
    • More information
    • FRANCE
    • RHONE-ALPES
    • CHAMBERY
    • FRANCE
    • LIMOUSIN
    • LIMOGES
    • Molecular diagnosis of predisposition to thrombosis (F5, F2 and MTHFR genes)
    • CHU de Limoges - Hôpital Dupuytren
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A variant; MTHFR gene: C677T and A1298C variants)
    • Nzoz Genomed
    • More information
    • ITALY
    • LOMBARDIA
    • BRESCIA
    • Molecular diagnosis of thrombophilia (FII, FV and MTHFR genes)
    • Biodiversity
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • IMEGEN - Instituto de Medicina Genómica
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of resistance to activated protein C (factor V Leiden, factor V Cambridge)
    • Molekulargenetisches Labor der Gemeinschaftspraxis
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Molekulargenetisches Labor der Gemeinschaftspraxis
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of MTHFR gene variant C677T
    • Molekulargenetisches Labor der Gemeinschaftspraxis
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
    • Molekulargenetisches Labor der Gemeinschaftspraxis
    • More information
    • FRANCE
    • LORRAINE
    • METZ
    • Molecular diagnosis of thrombophilia: factor V Leiden (gene F5 mutation G1691A) and factor II (gene F2 mutation G20210A)
    • CHR de Metz-Thionville
    • More information
    • CZECH REPUBLIC
    • Capital City Prague
    • PRAHA
    • Molecular diagnosis of non rare thrombophilia (MTHFR gene; F2 gene: G21210A variant; F5 gene: G1691A mutation)
    • GENvia Genetic Laboratory Ltd.
    • More information
    • FRANCE
    • AQUITAINE
    • VILLENAVE D'ORNON
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 Leiden genes)
    • Hôpital d'Instruction des Armées Robert PICQUE
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Molecular diagnosis of non rare thrombophilia (MTHFR gene variant C677T)
    • MVZ Humangenetik Ulm
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of thrombophilia (F2 gene: G20210A mutation)
    • Gemeinschaftspraxis für Humangenetik
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of factor V Leiden mutation
    • Gemeinschaftspraxis für Humangenetik
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Gemeinschaftspraxis für Humangenetik
    • More information
    • ITALY
    • TOSCANA
    • PRATO
    • Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
    • USL4 Ospedale Misericordia e Dolce
    • More information
    • CANADA
    • Québec
    • QUÉBEC
    • Molecular diagnosis of non rare thrombophilia (F5 gene / mutation G1691A)
    • CHUQ - Centre Hospitalier Universitaire de Québec - Hôtel-Dieu de Québec
    • More information
    • CANADA
    • Québec
    • QUÉBEC
    • Molecular diagnosis of non rare thrombophilia (F2 gene / mutation G20210A)
    • CHUQ - Centre Hospitalier Universitaire de Québec - Hôtel-Dieu de Québec
    • More information
    • CANADA
    • Québec
    • MONTRÉAL
    • Molecular diagnosis of Factor V Leiden thrombophillia (F5 gene: G1691A mutation by real-time PCR)
    • Centre hospitalier universitaire Sainte-Justine
    • More information
    • CANADA
    • Québec
    • MONTRÉAL
    • Molecular diagnosis of prothrombine-related thrombophilia (mutation G20210A of F2 gene)
    • Centre hospitalier universitaire Sainte-Justine
    • More information
    • CANADA
    • Québec
    • MONTRÉAL
    • Molecular diagnosis of MTHFR gene variant C677T
    • Centre hospitalier universitaire Sainte-Justine
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2, F5 genes)
    • CIBIR - Centro de Investigación Biomédica de La Rioja
    • More information
    • SPAIN
    • Andalucía
    • CÁDIZ
    • Molecular diagnosis of non rare thrombophilia (F5, F2, MTHFR genes)
    • Hospital Puerta del Mar
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A variant; MTHFR gene: C677T and A1298C variants)
    • MEDGEN
    • More information
    • SPAIN
    • Cataluña
    • TERRASSA
    • Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
    • Consorci Sanitari de Terrassa
    • More information
    • SPAIN
    • Andalucía
    • CAMPANILLAS
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2, F5 genes (C677T, A1298C, G20210A, G1691A) / real-time PCR)
    • GenoClinics
    • More information
    • PORTUGAL
    • CENTRO
    • OEIRAS
    • Molecular diagnosis of non rare thrombophilia (F5 gene mutation R506Q)
    • Laboratório de Análises Clínicas Dr. Joaquim Chaves
    • More information
    • PORTUGAL
    • CENTRO
    • OEIRAS
    • Analysis of thrombosis predisposition genetic factors (MTHFR: C667T e A1298C; F5: FV Leiden; F2: G20210A)
    • Laboratório de Análises Clínicas Dr. Joaquim Chaves
    • More information
    • PORTUGAL
    • ILHAS
    • FUNCHAL
    • Molecular diagnosis of non rare thrombophilia (F2 gene: Analysis of G20210A mutation by sequencing of the 3' region by qPCR)
    • Universidade da Madeira
    • More information
    • SPAIN
    • Comunidad Valenciana
    • ALICANTE
    • Molecular diagnosis of non rare thrombophilia (F5 gene / mutation G1619A; F2 gene / mutation G20210A)
    • Instituto Bernabeu Biotech
    • More information
    • ITALY
    • SICILIA
    • AVOLA
    • Molecular diagnosis of non rare trombophilia (FII, FV, MTHFR genes)
    • Laboratori Campisi s.r.l.
    • More information
    • SPAIN
    • Cataluña
    • TARRAGONA
    • Molecular diagnosis of polycythemia vera (F2 gene / 20210A mutation detection; F5 gene / R506Q mutation detection; MTHFR gene / C677T and A1298C mutations detection)
    • Hospital Universitari de Tarragona Joan XXIII
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of susceptibility to non rare thrombophilia (F2, F5, F12, MTHFR genes / PCR, region sequencing)
    • IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of non rare thrombophilia (F5 and F2 genes)
    • CHU Paris Est - Hôpital Tenon
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • CRÉTEIL
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A variant)
    • GH Henri Mondor
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • LE MANS
    • Phenotypic test of resistance to activated protein C
    • Centre hospitalier
    • More information
    • FRANCE
    • BRETAGNE
    • RENNES
    • Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
    • CHU de Rennes - Hôpital Pontchaillou
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • CLICHY
    • Molecular diagnosis of non rare thrombophilia (F5 gene: mutation G1691A; F2 gene: G20210A mutation; MTHFR gene: C677T mutation)
    • CHU Paris Nord-Val de Seine - Hôpital Beaujon
    • More information
    • FRANCE
    • HAUTE-NORMANDIE
    • ROUEN
    • Molecular diagnosis of non rare thrombophilia (F5, F and MTHFR genes)
    • CHU de Rouen - Hôpital Charles Nicolle
    • More information
    • FRANCE
    • LORRAINE
    • VANDOEUVRE-LÈS-NANCY
    • Diagnosis of resistance to activated protein C
    • CHU de Nancy - Hôpital de Brabois
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
    • Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Molecular diagnosis of resistance to activated protein C
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • More information
    • ITALY
    • BASILICATA
    • MATERA
    • Molecular diagnosis of hereditary thrombophilia (F5, MTHFR genes)
    • Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of thrombophilia (marker FV, FII, MTHFR, 4G/5G polymorphism in the promoter of the PAI1 gene)
    • Berlin-Potsdam MVZ GbR
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of factor V Leiden mutation
    • Praxis Dr. med. Ulrike Beudt
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of MTHFR gene variant C677T
    • Praxis Dr. med. Ulrike Beudt
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Praxis Dr. med. Ulrike Beudt
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Humangenetische Praxis Dr. Schmidt & Mautner
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Molecular diagnosis of factor V Leiden mutation
    • Humangenetische Praxis Dr. Schmidt & Mautner
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Humangenetische Praxis Dr. Schmidt & Mautner
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Molecular diagnosis of thrombophilia (SERPINE1 gene: 4G/5G polymorphism, 844 A/G)
    • Humangenetische Praxis Dr. Schmidt & Mautner
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
    • Universitäts-Kinderklinik und Poliklinik
    • More information
    • ITALY
    • CALABRIA
    • REGGIO CALABRIA
    • Molecular diagnosis of resistance to activated protein C
    • Azienda Ospedaliera BMM
    • More information
    • SPAIN
    • Andalucía
    • GRANADA
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • Hospital Universitario San Cecilio
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of thrombosis risks (F5 and F2 genes)
    • CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
    • CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Lariboisière
    • More information
    • GERMANY
    • Bayern
    • NÜRNBERG
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Medizinisches Versorgungszentrum
    • More information
    • GERMANY
    • Bayern
    • NÜRNBERG
    • Molecular diagnosis of factor V Leiden mutation
    • Medizinisches Versorgungszentrum
    • More information
    • GERMANY
    • Bayern
    • NÜRNBERG
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Medizinisches Versorgungszentrum
    • More information
    • GERMANY
    • Bayern
    • NÜRNBERG
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the SERPINE1 gene)
    • Medizinisches Versorgungszentrum
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • ARGENTEUIL
    • Molecular diagnosis of non rare thrombophilia (F2 and F5 genes)
    • Centre hospitalier Victor Dupouy
    • More information
    • ITALY
    • CALABRIA
    • MANGONE
    • Molecular diagnosis of risk factors for thrombophilia (F2, F5, MTHFR genes)
    • CNR
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BAD OEYNHAUSEN
    • Molecular diagnosis of MTHFR gene variant C677T
    • Ruhr-Universität Bochum
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BAD OEYNHAUSEN
    • Molecular diagnosis of factor V Leiden mutation
    • Ruhr-Universität Bochum
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Molecular diagnosis of resistance to activated protein C (factor V Leiden)
    • Medizinische Universität Graz
    • More information
    • ITALY
    • SARDEGNA
    • OZIERI
    • Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
    • Presidio Ospedaliero di Ozieri - ASL 1
    • More information
    • ITALY
    • SICILIA
    • MESSINA
    • Molecular diagnosis of thrombophilia (F2, F5, MTHFR genes)
    • A.O.U. Policlinico "G. Martino"
    • More information
    • GERMANY
    • Hessen
    • DARMSTADT
    • Molecular diagnosis of thrombophilia (4G/5G polymorphism in the promoter of the PAI1 gene)
    • Klinikum Darmstadt GmbH
    • More information
    • GERMANY
    • Hessen
    • DARMSTADT
    • Molecular diagnosis of MTHFR gene variants C677T and A1298C
    • Klinikum Darmstadt GmbH
    • More information
    • GERMANY
    • Hessen
    • DARMSTADT
    • Risk calculation on molecular basis for thrombophilia (F2 gene: G20210A mutation)
    • Klinikum Darmstadt GmbH
    • More information
    • GERMANY
    • Hessen
    • DARMSTADT
    • Molecular diagnosis of factor V Leiden mutation
    • Klinikum Darmstadt GmbH
    • More information
    • ITALY
    • LOMBARDIA
    • SAN FERMO DELLA BATTAGLIA
    • Molecular diagnosis of thrombophilia risks (F2, F5, MTHFR)
    • Azienda Ospedaliera S. Anna
    • More information
    • FINLAND
    • Finland
    • TURKU
    • Molecular diagnosis of factor V Leiden
    • Turku University Hospital
    • More information
    • SPAIN
    • Andalucía
    • GRANADA
    • Molecular Diagnosis of Hyperprothombinemia
    • Hospital Universitario Virgen de las Nieves
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of non rare thrombophilia (F2, F5 and MTHFR genes)
    • Hospital San Pedro
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
    • USI - Unione Sanitaria Internazionale
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of Predisposition to thrombophilia. F5 gene
    • DNA Data
    • More information
    • ITALY
    • LOMBARDIA
    • LODI
    • Molecular diagnosis of resistance to activated protein C (F5 gene)
    • Azienda Ospedaliera della Provincia di Lodi
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Molecular diagnosis of Predisposition to thrombophilia (specific F5 & F2 mutations)
    • Cliniques Universitaires UCL de Saint Luc - UCLStLuc
    • More information
    • UNITED KINGDOM
    • Oxfordshire
    • OXFORD
    • Molecular diagnosis of Thrombophilia (F5, F2 genes)
    • John Radcliffe Hospital
    • More information
    • CZECH REPUBLIC
    • Usti nad Labem
    • USTI NAD LABEM
    • Molecular diagnosis of non rare thrombophilia (F2 gene: G20210A variant; F5 gene: Leiden mutation; MTHFR gene)
    • Masaryk hospital
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of factor V Leiden
    • BURC Genetics Diagnostic Center
    • More information
    • SLOVENIA
    • SLOVENIA
    • LJUBLJANA
    • Molecular diagnosis of factor V Leiden thrombophilia (F5 gene)
    • University Medical Center Ljubljana
    • More information
    • DENMARK
    • Fyn
    • ODENSE
    • Molecular diagnosis of resistance to activated protein C (RFLP analysis of F5 gene)
    • Amplexa Genetics A/S
    • More information
    • DENMARK
    • Fyn
    • ODENSE
    • Molecular diagnosis of factor II deficiency (RFLP analysis of F2 gene)
    • Amplexa Genetics A/S
    • More information
    • LATVIA
    • LATVIA
    • RIGA
    • Molecular diagnosis of Factor V Deficiency (Leiden)
    • BMC - Biomedical Research centre
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Molecular diagnosis of Thrombophilia (APCR, MTHFR, Prothrombin, Mutation analysis)
    • The Bnai Zion Medical Center, Technion-Rappaport Faculty of Medicine
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Molecular diagnosis of Hypercoagulation (FV, Prothrombin, MTHFR, Mutation analysis)
    • Shaare Zedek Medical Center
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ-NAPOCA
    • Molecular diagnosis of MTHFR deficiency (C677T, A1298C and G1793A/T mutations)
    • Spitalul Judetean Clinc de Urgenta Cluj
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ-NAPOCA
    • Molecular diagnosis of hyperprothrombinemia (mutation G20210A of F2 gene)
    • Spitalul Judetean Clinc de Urgenta Cluj
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ-NAPOCA
    • Molecular diagnosis of resistance to activated protein C (F5 Leiden mutation)
    • Spitalul Judetean Clinc de Urgenta Cluj
    • More information
    • POLAND
    • Lodz
    • LODZ
    • Molecular diagnosis of resistance to activated protein C (F5 gene : Leiden mutation)
    • Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
    • More information
    • POLAND
    • Lodz
    • LODZ
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene: G20210A variant; MTHFR gene: C677T and A1298C variants)
    • Uniwersytecki Szpital Kliniczny
    • More information
    • CZECH REPUBLIC
    • Capital City Prague
    • PRAHA
    • Molecular diagnosis of factor V deficiency (F5 gene)
    • Sanatorium PRONATAL
    • More information
    • CZECH REPUBLIC
    • Capital City Prague
    • PRAHA
    • Molecular diagnosis of non rare thrombophilia (F2 gene: G20210A mutation; F5 gene: Leiden mutation)
    • Sanatorium PRONATAL
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Molecular diagnosis of Factor V Leiden mutation (G1691A mutation)
    • King's College Hospital
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • TOULON
    • Molecular diagnosis of thrombosis risks (F5 and F2 genes)
    • CHI Toulon La Seyne-sur-Mer - Hôpital Sainte Musse
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of resistance to activated protein C (F5 gene mutations)
    • Mitera General, Maternity and Children's Hospital
    • More information
    • FRANCE
    • CENTRE
    • MONTARGIS
    • Molecular diagnosis of thrombophilia risks (F5 gene: Leiden mutation; F2 gene: G20210A mutation; real-time PCR analysis)
    • MEDIBIO
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • CORBEIL-ESSONNES
    • Molecular diagnosis of non rare thrombophilia (F5 gene: Leiden mutation; F2 gene; G20210A variant)
    • Centre Hospitalier Sud Francilien
    • More information
    • POLAND
    • Kraków
    • CRACOW
    • Molecular diagnosis of non rare thrombophilia (F2 gene: G20210A mutation; MTHFR gene: C677T variant)
    • CM UJ Jagiellonian University Medical College
    • More information
    • GREECE
    • IRAKLIO
    • HERAKLION
    • Molecular diagnosis of non rare thrombophilia (F5 gene:Leiden and H1299R mutations; F2 gene: G20210A mutation; MTHFR: C677T and A1298C variants)
    • DNA analysis
    • More information
    • CZECH REPUBLIC
    • Capital City Prague
    • PRAHA
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • IHBT - Institute of hematology and blood transfusion
    • More information
    • CZECH REPUBLIC
    • Olomouc
    • OLOMOUC
    • Molecular diagnosis of non rare thrombophilia (F5, F2 and MTHFR genes)
    • University hospital Olomouc
    • More information
    • CZECH REPUBLIC
    • South Bohemia
    • CESKE BUDEJOVICE
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • Hospital Ceské Budejovice
    • More information
    • CZECH REPUBLIC
    • Liberec
    • LIBEREC
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • Regional Hospital Liberec, Krajska nemocnice Liberec
    • More information
    • CZECH REPUBLIC
    • Plzen
    • PLZEN
    • Molecular diagnosis of non rare thrombophilia (MTHFR, F2 and F5 genes)
    • Genomia s.r.o.
    • More information
    • SPAIN
    • Andalucía
    • ARMILLA
    • Molecular diagnosis of non rare thrombophilia (F2 gene / G20210A mutation, F5 gene / G1691A mutation and MTHFR gene / C677T mutation)
    • Lorgen G.P.
    • More information
    • SPAIN
    • Madrid
    • MAJADAHONDA
    • Molecular diagnosis of non rare thrombophilia (F5 and MTHFR genes)
    • Genyca Innova
    • More information
    • ITALY
    • SICILIA
    • SIRACUSA
    • Molecular diagnosis of non rare thrombophilia (F2, F5, MTHFR genes)
    • Centro Analisi Cliniche Srl
    • More information
    • FRANCE
    • CENTRE
    • CHAMBRAY-LES-TOURS
    • Molecular diagnosis of non rare thrombophilia (F2, F5 genes)
    • SELAS Arnaud-Biolys-Origet
    • More information
    • SLOVAKIA
    • Bratislavsky kraj
    • BRATISLAVA
    • Molecular diagnosis of hereditary thrombophilia (F5 gene: G1591A and H1299R; F2 gene: G20210A; MTHFR gene: C677T and A1298C; F13A1 gene: V34L; PROCR gene: A4600G and G4678C; 4G/5G polymorphism in the promoter of the PAI1 gene)
    • University Hospital Bratislava - Stare mesto
    • More information